ArticleJournal of neurology, neurosurgery, and psychiatry2006

Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).

C Hirst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.